Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) is a revolutionary surgical procedure that allows replacement of the diseased endothelium in cases of endothelial corneal dystrophies ...

GDDs significantly increase corneal edema risk compared to trabeculectomy, with a 27.7% incidence versus 13.5% for trabeculectomy. MIGS and Xen stents show lower risks for corneal edema, with ...

Findings of post hoc analyses published in JAMA Ophthalmology suggest that preoperative Scheimpflug imaging can help predict corneal edema resolution following Descemet membrane endothelial ...

Ricinus communis seed oil, or castor oil, has been used by Indians for various ailments. Ricinoleic acid, either in its salt or ester form, is often used in skin-conditioning agents, emulsion ...

Please provide your email address to receive an email when new articles are posted on . There is a “wow” effect from refractive cataract surgery because we can eliminate the lens opacity and address ...

SEATTLE & CAMBRIDGE, Mass. & TOKYO, April 08, 2026--(BUSINESS WIRE)--Aurion Biotech, Inc. ("Aurion Biotech"), a commercial-stage regenerative cell therapy company dedicated to restoring vision and ...

Researchers at Harvard Medical School have demonstrated the potent therapeutic effects of administration of the neuropeptide α-melanocyte–stimulating hormone (α-MSH) through melanocortin receptor ...

Iridocorneal Endothelial Syndrome is a rare eye diseases that causes swelling inside the cornea and changes in the iris (the colored part of your eye). Because Iridocorneal Endothelial Syndrome causes ...

Hazy vision is a symptom of corneal edema secondary to endothelial dysfunction. (Aurion Biotech Image) Aurion Biotech has raised $120 million to advance its cell therapy for an eye disorder that ...

Swelling commonly occurs in the corneas of mountain climbers, but does not appear to affect vision at altitudes of up to 6,300 meters (about 20,670 feet), according to a report in the February issue ...

Aurion Biotech, Inc. ("Aurion Biotech"), a commercial-stage regenerative cell therapy company dedicated to restoring vision and working toward a future where blindness is eliminated, today announced ...